台灣泌尿科醫學會E-School

台灣泌尿科醫學會E-School

MP01-01: The effect of urinary retention on serum prostate specific antigen after inguinal hernia repair under spinal anesthesia

2024-12-20 • 觀看: 408 • 回應: 0 • doc
PD03-06: The Role of p53 in Monoamine Oxidase B Inhibition of Renal Cell Carcinoma Progression

2024-12-20 • 觀看: 385 • 回應: 0 • doc
PD03-05: A single center experience review of partial cystectomy from 2018 to 2021

2024-12-20 • 觀看: 407 • 回應: 0 • doc
PD03-04: Comparative Follow-up Study of Salvage Radiation Therapy versus Androgen-Deprivation Therapy for Localized Prostate Cancer with Biochemical Recurrence after Robotic-Assisted Radical Prostatectomy: A Single Center Experience

2024-12-20 • 觀看: 385 • 回應: 0 • doc
PD03-03: Preliminary results of Neoadjuvant therapy with Enfortumab vedotin and Pembrolizumab in urothelial carcinoma patients

2024-12-20 • 觀看: 557 • 回應: 0 • doc
PD03-02: Analysis of Performance of 4 AI LLMs in Stage IV Prostate Cancer Risk Assessment and Information Retrieval

2024-12-19 • 觀看: 376 • 回應: 0 • doc
PD03-01: Androgen deprivation-induced interleukin 1 receptor antagonist upregulation promotes immunosuppression and neuroendocrine differentiation in prostate cancer

2024-12-19 • 觀看: 400 • 回應: 0 • doc
PD02-06: Therapeutic Benefits of Chemohyperthermia: Boosting Epirubicin Uptake and Modulating the Tumor Microenvironment in Bladder Cancer

2024-12-19 • 觀看: 400 • 回應: 0 • doc
PD02-05: Down-regulation of Aquaporins Sensitizes Immune Check-point inhibitors -induced Cytotoxicity of urothelial carcinoma

2024-12-19 • 觀看: 395 • 回應: 0 • doc
PD02-04: Comparative Study of Ureteral Access Sheath versus Suction Access Sheath in Retrograde Intrarenal Surgery

2024-12-19 • 觀看: 426 • 回應: 0 • doc
PD02-03: Exploring the Risk of Nephrolithiasis Associated with Glucagon-like Peptide-1 Agonists: A Retrospective TriNetX Data Analysis

2024-12-19 • 觀看: 462 • 回應: 0 • doc
PD02-02: Dapagliflozin inhibits kidney stones via modulating autophagy

2024-12-19 • 觀看: 449 • 回應: 0 • doc

Prev
47
48
49
50
51
52
53
54
55
56
Next
/ 1052